CathSource vs STEMIcathAID

CathSource (from the creators of ECGsource) is an up-to-date medical reference devoted exclusively to cardiac catheterization and angiography. Developed by practicing Interventional Cardiologists for both specialists and trainees in the field of cardiovascular disease, CathSource offers the following content: * Searchable index of specialized topics including: Normal Coronary Anatomy Anomalous Coronary Arteries Coronary Artery Aneurysms Myocardial Bridging Takotsubo Cardiomyopathy Plaque Rupture & Thrombus Standard Views of Angiography Left Ventriculography Coarctation of the Aorta Femoral Artery Access for Angiography Radial Artery Access for Angiography Intravascular Ultrasound (IVUS) Optical Coherence Tomography (OCT) Fractional Flow Reserve (FFR) Hemodynamics: Intracardiac Pressures Hemodynamics: Intracardiac Waveforms Hemodynamics: Cardiac Output Hemodynamics: Intracardiac Shunts Hemodynamics: Aortic Stenosis Hemodynamcis: Aortic Regurgitation Hemodynamics: Mitral Stenosis Hemodynamcis: Mitral Regurgitation Hemodynamcis: Constriction Hemodynamics: Restriction * Searchable database containing more than 30 videos (coronary angiograms, ventriculograms, and aortograms) of both common and rare findings in the cardiac catheterization lab * Searchable database of over 65 images including hemodynamic formulas, tables, and figures CathSource provides a detailed overview of important cardiac catheterization and angiography topics, incorporating educational images/videos as well as reviews of pertinent medical literature. CathSource is the ideal application to assist you in understanding and recognizing cardiovascular pathology in the catheterization lab.

STEMIcathAID is a patient recognition, response, and record-keeping system designed to improve outcomes through adherence the American Heart Association’s Mission:Lifeline STEMI guidelines. Early restoration of blood flow to occluded coronary vessels has been shown to significantly improve outcomes for high-risk STEMI patients. STEMIcathAID aims to improve these clinical outcomes by optimizing their treatment following many of the recommendations of the AHA by reducing the time to STEMI recognition, lead acquisition, STEMI identification, notification of the catheterization lab, and reperfusion. There are multiple personnel and steps involved in caring for these high-risk patients. STEMIcathAID takes an algorithmic approach which will enhance the coordination and communication tasks essential to rapid assessment and easy transfer of STEMI patients from the field or outside facility. It will also provide protocols for the EMS or outside hospital provider to identify patients in cardiogenic shock even before their arrival in the catheterization lab. The application will integrate live GPS tracking of the patients alongside the time the alarm was raised prompting the sense of urgency in transferring the patient. Incorporating images, videos, illustrations, and live GPS tracking of the EMS, the design will be subdivided into three main sections: 1. EKG Upload by outside facility or EMS 2. Assessment of Cardiogenic Shock 3. STEMI patient transfer pathway When a medical provider, in the field, other hospital, or outpatient office, suspects STEMI, the provider uploads the EKG by taking a picture of it with their phone. Once the EKG is uploaded, the on-call attending at the PCI-capable facility receives a notification from the application. If the attending believes the patient is experiencing a real STEMI, the pathway is activated. Upon activation, the approximately 10-12 people involved in taking care of the patient are notified so they can begin preparations. Adhering to HIPAA compliance, all users log into the encrypted application and begin to collaborate such aspects as patient vitals, shock information, and emergency vehicle current location and estimated arrival time to the cath lab. Through the optimized communication and collaboration of multiple key players in the STEMI pathway, these time-critical, vulnerable patients can begin treatment promptly.